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To the editor: Two recent publications by Reinheimer et 
al. and Heudorf et al. in Eurosurveillance, provided data 
on multidrug-resistant bacteria obtained from screen-
ing of different refugee populations and concluded 
that additional screening or surveillance for refugees at 
hospital admission in Germany should be undertaken 
[1,2]. The high number of people currently migrating 
to Europe from disaster areas has sparked a debate, 
whether or not refugees should be screened at hospi-
tal admission for colonisation with multidrug-resistant 
bacteria to limit spread of antibiotic resistance within 
Europe. The possible negative consequences of screen-
ing and lacking data make this a more complex issue 
than it may seem at first.
The advantages of screening seem obvious. There is 
evidence that in some countries with a high emigration 
the prevalence of antimicrobial resistance in health-
care settings is high. In addition, international travel 
and migration are discussed as factors promoting the 
global spread of resistance [3]. One could also specu-
late that resistant pathogens may spread during the 
journey or within refugee camps, where hygiene is 
often poor and turnover of persons is high. However, 
evidence to base a decision for or against microbiologi-
cal screening in refugees is largely lacking.
Little can be done in terms of decolonisation in case of 
multidrug-resistant Gram-negative bacteria (MDRGN), 
because they can colonise the human gut and become 
part of the intestinal flora. Therefore, good adherence 
to infection control precautions is essential to prevent 
the transmission of MDRGN in hospitals. In addition 
to standard precautions, isolation and barrier nursing 
are possible intervention strategies. However, these 
measures may be associated with poorer patient care 
[4] and higher cost. In the context of refugees it is 
also perceivable that targeted screening will result in 
stigmatisation.
Given the scarcity of available data in the scientific lit-
erature, the recently published articles by Reinheimer 
et al. and Heudorf et al. [1,2] are highly interesting. They 
show that in a sample of 143 adult refugees present-
ing at a German hospital as well as among 119 unac-
companied refugee minors, colonisation with extended 
spectrum beta-lactamase (ESBL)-producing bacteria is 
more frequent than in patients from general German 
population. Both articles suggest additional screen-
ing or surveillance for refugees at hospital admission 
in Germany. The Robert Koch Institute on the other 
hand does not recommend screening particularly for 
refugees in addition to what is recommended for eve-
ryone at hospital admission in Germany: if a patient 
had recent contact to the healthcare system of coun-
tries with high prevalence of antimicrobial resistance, 
screening for carbapenem-resistant bacteria and meti-
cillin-resistant Staphylococcus aureus (MRSA) is recom-
mended [5]. Reinheimer et al. calculated that according 
to current German guidelines [6], 32.9% of refugees in 
contrast to 10.9% of non-refugee patients would qual-
ify for isolation in especially vulnerable settings, such 
as intensive care units (ICUs). This is misleading since 
not all of the patients in their sample had to be admit-
ted to such settings.
While the high rate of colonisation with ESBL-producing 
bacteria among refugees is certainly worrisome and 
while current guidelines indeed recommend isolation 
in certain settings, such as in ICUs, screening for these 
pathogens is not recommended for any patient group 
in Germany [6]. In addition, colonisation with ESBL-
producing bacteria may also be high in some German 
populations. For example a study among travellers 
returning to Germany showed colonisation with ESBL-
producing Escherichia coli in 30% [3], which is similar 
to that seen among refugee minors [2]. Screening is, 
however, not recommended for travellers returning to 
Germany.
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As described above screening for carbapenem-resist-
ant bacteria is recommended for high risk groups [6]. 
Fortunately, carbapenem resistance was low in both 
studies, so that the need for targeted screening in this 
population under current German guidelines does not 
seem to be warranted. If, however, the proposal of an 
extension of current screening criteria was intended, 
Germans at high risk for colonisation with ESBL-
producing bacteria needed to be included too. In the 
meantime strengthening standard hospital hygiene 
and providing translators for refugees to ensure good 
patient care and to identify those patients, who qualify 
for isolation and screening under current guidelines, 
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